All News

In a video interview with Drug Topics®, Robert Brunault, PharmD, a clinical pharmacy specialist of hematology and oncology at Rhode Island Hospital and Lifespan Cancer Institute, answers questions about how the COVID-19 pandemic affects patients undergoing treatment for cancer.

Here's a roundup of the latest coronavirus-related news.

The letter asks the vice president to increase manufacturing of these medications based on current projections of critical care patient volume.

What does it mean for patients?

The findings highlight the importance of continuing to follow strict preventative measures, the CDC report said.

Pharmacists are positioned to play a key role in preventing or catching errors that can occur at the various stages of the drug-use process: prescribing, dispensing, and administration.

Expanding COVID-19 testing is "a critical component in our nation's efforts to reduce the number of cases, ease burdens on our over-utilized hospitals and clinics, and protect the safety of our communities," the Pharmacists for Healthier Lives coalition said.

Pharmacies that haven’t added digital marketing and advertising to their mix are missing the target.

The FDA has approved lumateperone tosylate (Caplyta™, Intra-Cellular Therapies) for treatment of schizophrenia in adults.

The announcement follows recent albuterol shortages reports due to the COVID-19 pandemic.

Pharmacists can play an integral role in managing patients with diabetes.

As COVID-19 continues to spread, and the death toll rises, experts aim to better understand the clinical features of the disease and factors for increased mortality.

Pharmacists weigh in on how to bring this generation to the pharmacy.

Autoimmunity and certain autoimmune diseases have been increasing in prevalence in the United States.

Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.

According to the findings, on average, only 6% of actual SARS-CoV-2 infections have been detected worldwide, meaning that the vast majority of infections have gone undetected.

The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.

Pharmacies, just as expected, have showed up in meaningful ways to support their communities.

The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.

The FDA’s public- and private-sector partnership will expedite thousands of units of plasma to patients with severe COVID-19 symptoms, the news release said.

Officials with the FDA have granted approval to ixekizumab (Taltz, Eli Lilly) injection, 80 mg/mL for the treatment of pediatric patients with moderate-to-severe plaque psoriasis.

Officials with the FDA have approved luspatercept-aamt (Reblozyl, Bristol Myers Squibb and Acceleron Pharma) for the treatment of anemia in adults with lower-risk myelodysplastic syndromes.

Facing disruptions in medical mask supplies, some hospital staff are re-using masks and using alternative types, according to a new survey.

Here's a roundup of the latest coronavirus-related news.

Coagulation factor VIIa (recombinant)-jncw (Sevenfact, LBF) contains an active ingredient from a genetically engineered animal.

Obesity may contribute to incident long-term prescription opioid use due to underlying pain conditions.

During times like these, we must come together and help those in need.

Rimegepant (Nurtec ODT, Biohaven Pharmaceuticals) reduced monthly migraine days in patients with episode and chronic migraine in a clinical trial.